Selected research
Industry Research
Airsickness Treatment Drug Industry Research Report 2026
Market perspective
The global Airsickness Treatment Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Airsickness Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Airsickness Treatment Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Airsickness Treatment Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Airsickness Treatment Drug include Sandoz, Mylan, Pfizer, GlaxoSmithKline, Baxter International, WellSpring Pharmaceutical Corporation, Prestige Brands, Myungmoon Pharm and Caleb Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Airsickness Treatment Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Airsickness Treatment Drug Market by Company
Sandoz
Mylan
Pfizer
GlaxoSmithKline
Baxter International
WellSpring Pharmaceutical Corporation
Prestige Brands
Myungmoon Pharm
Caleb Pharmaceuticals
Airsickness Treatment Drug Segment by Type
Anticholinergic
Antihistamines
Airsickness Treatment Drug Segment by Application
Adults
Children
Airsickness Treatment Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Airsickness Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Airsickness Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Airsickness Treatment Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Airsickness Treatment Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Airsickness Treatment Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Airsickness Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anticholinergic
- Antihistamines
Applications
- Adults
- Children
Companies covered
- Sandoz
- Mylan
- Pfizer
- GlaxoSmithKline
- Baxter International
- WellSpring Pharmaceutical Corporation
- Prestige Brands
- Myungmoon Pharm
- Caleb Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Airsickness Treatment Drug Market Size (2021-2032)
- 2.2.2 Global Airsickness Treatment Drug Sales (2021-2032)
- 2.2.3 Global Airsickness Treatment Drug Market Average Price (2021-2032)
- 2.3 Airsickness Treatment Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anticholinergic
- 2.3.3 Antihistamines
- 2.4 Airsickness Treatment Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Airsickness Treatment Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Airsickness Treatment Drug Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Airsickness Treatment Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Airsickness Treatment Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Airsickness Treatment Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Airsickness Treatment Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Airsickness Treatment Drug, Product Type & Application
- 3.8 Global Manufacturers of Airsickness Treatment Drug, Established Date
- 3.9 Global Airsickness Treatment Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sandoz
- 4.1.1 Sandoz Company Information
- 4.1.2 Sandoz Business Overview
- 4.1.3 Sandoz Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sandoz Airsickness Treatment Drug Product Portfolio
- 4.1.5 Sandoz Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Airsickness Treatment Drug Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Airsickness Treatment Drug Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Airsickness Treatment Drug Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Baxter International
- 4.5.1 Baxter International Company Information
- 4.5.2 Baxter International Business Overview
- 4.5.3 Baxter International Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Baxter International Airsickness Treatment Drug Product Portfolio
- 4.5.5 Baxter International Recent Developments
- 4.6 WellSpring Pharmaceutical Corporation
- 4.6.1 WellSpring Pharmaceutical Corporation Company Information
- 4.6.2 WellSpring Pharmaceutical Corporation Business Overview
- 4.6.3 WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Product Portfolio
- 4.6.5 WellSpring Pharmaceutical Corporation Recent Developments
- 4.7 Prestige Brands
- 4.7.1 Prestige Brands Company Information
- 4.7.2 Prestige Brands Business Overview
- 4.7.3 Prestige Brands Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prestige Brands Airsickness Treatment Drug Product Portfolio
- 4.7.5 Prestige Brands Recent Developments
- 4.8 Myungmoon Pharm
- 4.8.1 Myungmoon Pharm Company Information
- 4.8.2 Myungmoon Pharm Business Overview
- 4.8.3 Myungmoon Pharm Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Myungmoon Pharm Airsickness Treatment Drug Product Portfolio
- 4.8.5 Myungmoon Pharm Recent Developments
- 4.9 Caleb Pharmaceuticals
- 4.9.1 Caleb Pharmaceuticals Company Information
- 4.9.2 Caleb Pharmaceuticals Business Overview
- 4.9.3 Caleb Pharmaceuticals Airsickness Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Caleb Pharmaceuticals Airsickness Treatment Drug Product Portfolio
- 4.9.5 Caleb Pharmaceuticals Recent Developments
5 Global Airsickness Treatment Drug Market Scenario by Region
- 5.1 Global Airsickness Treatment Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Airsickness Treatment Drug Sales by Region: 2021-2032
- 5.2.1 Global Airsickness Treatment Drug Sales by Region: 2021-2026
- 5.2.2 Global Airsickness Treatment Drug Sales by Region: 2027-2032
- 5.3 Global Airsickness Treatment Drug Revenue by Region: 2021-2032
- 5.3.1 Global Airsickness Treatment Drug Revenue by Region: 2021-2026
- 5.3.2 Global Airsickness Treatment Drug Revenue by Region: 2027-2032
- 5.4 North America Airsickness Treatment Drug Market Facts & Figures by Country
- 5.4.1 North America Airsickness Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Airsickness Treatment Drug Sales by Country (2021-2032)
- 5.4.3 North America Airsickness Treatment Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Airsickness Treatment Drug Market Facts & Figures by Country
- 5.5.1 Europe Airsickness Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Airsickness Treatment Drug Sales by Country (2021-2032)
- 5.5.3 Europe Airsickness Treatment Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Airsickness Treatment Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Airsickness Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Airsickness Treatment Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Airsickness Treatment Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Airsickness Treatment Drug Market Facts & Figures by Country
- 5.7.1 South America Airsickness Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Airsickness Treatment Drug Sales by Country (2021-2032)
- 5.7.3 South America Airsickness Treatment Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Airsickness Treatment Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Airsickness Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Airsickness Treatment Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Airsickness Treatment Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Airsickness Treatment Drug Sales by Type (2021-2032)
- 6.1.1 Global Airsickness Treatment Drug Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Airsickness Treatment Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Airsickness Treatment Drug Revenue by Type (2021-2032)
- 6.2.1 Global Airsickness Treatment Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Airsickness Treatment Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Airsickness Treatment Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Airsickness Treatment Drug Sales by Application (2021-2032)
- 7.1.1 Global Airsickness Treatment Drug Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Airsickness Treatment Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Airsickness Treatment Drug Revenue by Application (2021-2032)
- 7.2.1 Global Airsickness Treatment Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Airsickness Treatment Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Airsickness Treatment Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Airsickness Treatment Drug Value Chain Analysis
- 8.1.1 Airsickness Treatment Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Airsickness Treatment Drug Production Mode & Process
- 8.2 Airsickness Treatment Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Airsickness Treatment Drug Distributors
- 8.2.3 Airsickness Treatment Drug Customers
9 Global Airsickness Treatment Drug Analyzing Market Dynamics
- 9.1 Airsickness Treatment Drug Industry Trends
- 9.2 Airsickness Treatment Drug Industry Drivers
- 9.3 Airsickness Treatment Drug Industry Opportunities and Challenges
- 9.4 Airsickness Treatment Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst